[68Ga]Ga-DOTA-FAPI-04 PET/CT imaging in a case of prostate cancer with shoulder arthritis
- PMID: 32901354
- DOI: 10.1007/s00259-020-05028-x
[68Ga]Ga-DOTA-FAPI-04 PET/CT imaging in a case of prostate cancer with shoulder arthritis
Similar articles
-
Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings.Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):73-86. doi: 10.1007/s00259-020-04940-6. Epub 2020 Jun 25. Eur J Nucl Med Mol Imaging. 2021. PMID: 32588089
-
Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer.Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1820-1832. doi: 10.1007/s00259-020-04769-z. Epub 2020 Mar 28. Eur J Nucl Med Mol Imaging. 2020. PMID: 32222810
-
[68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancer.Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2078-2079. doi: 10.1007/s00259-020-04847-2. Epub 2020 May 8. Eur J Nucl Med Mol Imaging. 2020. PMID: 32385646 No abstract available.
-
68Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.Eur Urol Focus. 2018 Sep;4(5):686-693. doi: 10.1016/j.euf.2016.11.002. Epub 2016 Nov 15. Eur Urol Focus. 2018. PMID: 28753806
-
Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature.BJU Int. 2020 Feb;125(2):206-214. doi: 10.1111/bju.14944. Epub 2019 Nov 29. BJU Int. 2020. PMID: 31680398 Free PMC article. Review.
Cited by
-
[68Ga]Ga-FAPI versus 2-[18F]FDG PET/CT in patients with autoimmune thyroiditis: a case control study.EJNMMI Res. 2024 Jul 18;14(1):66. doi: 10.1186/s13550-024-01129-y. EJNMMI Res. 2024. PMID: 39023777 Free PMC article.
-
FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis?Cancers (Basel). 2021 Sep 30;13(19):4946. doi: 10.3390/cancers13194946. Cancers (Basel). 2021. PMID: 34638433 Free PMC article. Review.
-
FAPI PET/CT in the Diagnosis of Abdominal and Pelvic Tumors.Front Oncol. 2022 Jan 4;11:797960. doi: 10.3389/fonc.2021.797960. eCollection 2021. Front Oncol. 2022. PMID: 35059319 Free PMC article. Review.
-
Evaluation of FAPI PET imaging in gastric cancer: a systematic review and meta-analysis.Theranostics. 2023 Aug 21;13(13):4694-4710. doi: 10.7150/thno.88335. eCollection 2023. Theranostics. 2023. PMID: 37649615 Free PMC article.
-
Clinical advancement of precision theranostics in prostate cancer.Front Oncol. 2023 Feb 2;13:1072510. doi: 10.3389/fonc.2023.1072510. eCollection 2023. Front Oncol. 2023. PMID: 36816956 Free PMC article. Review.
References
-
- Lay AJ, Zhang HE, McCaughan GW, et al. Fibroblast activation protein in liver fibrosis. Front Biosci. 2019;24:1–17. - DOI
-
- Khreish F, Rosar F, Kratochwil C, et al. Positive FAPI-PET/CT in a metastatic castration-resistant prostate cancer patient with PSMA-negative/FDG-positive disease. Eur J Nucl Med Mol Imaging. 2019. https://doi.org/10.1007/s00259-019-04623-x .
-
- Giesel FL, Heussel CP, Lindner T, et al. FAPI-PET/CT improves staging in a lung cancer patient with cerebral metastasis. Eur J Nucl Med Mol Imaging. 2019;46(8):1754–5. - DOI
-
- Koerber SA, Staudinger F, Kratochwil C, et al. The role of FAPI-PET/CT for patients with malignancies of the lower gastrointestinal tract – first clinical experience. J Nucl Med. 2020. https://doi.org/10.2967/jnumed.119.237016 .
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical